Loading...
•
Sep 30
•/
Philips Q3 2025 Earnings Report
Philips delivered Q3 2025 results with higher order intake, modest sales growth, and improved margins driven by productivity and strong segment contributions.
Key Takeaways
Philips reported solid performance in Q3 2025 with sales of €4.3 billion, a 3.3% increase in comparable terms. Net income and operating income both showed strength, supported by margin expansion and cost discipline. Strong order intake and growth across all segments underscored the company’s momentum.
Group sales reached €4.3 billion with 3.3% comparable growth.
Operating income came in at €330 million.
Free cash flow rose to €172 million.
Adjusted EBITA margin improved by 50 basis points to 12.3%.
Philips
Philips
Philips Revenue by Segment
Philips Revenue by Geographic Location
Revenue by Segment
Diagnosis & Treatment Revenue
CapyFin.comConnected Care Revenue
CapyFin.comPersonal Health Revenue
CapyFin.comOther Revenue
CapyFin.comRevenue by Geographic Location
Western Europe Revenue
CapyFin.comNorth America Revenue
CapyFin.comOther Mature Geographies Revenue
CapyFin.comGrowth Geographies Revenue
CapyFin.com Forward Guidance
Philips reaffirmed its full-year 2025 guidance, expecting margins at the upper end of the range and maintaining sales growth targets despite macroeconomic uncertainty.
Positive Outlook
- Adjusted EBITA margin expected toward upper end of 11.3%-11.8%.
- Free cash flow projected between €0.2–€0.4 billion.
- Continued strong order intake in North America.
- Productivity savings on track toward €800 million for 2025.
- Growth expected in all business segments.
Challenges Ahead
- Macroeconomic uncertainty remains a risk.
- Tariff increases pressured margins.
- Respironics-related legal proceedings ongoing.
- Supply chain volatility requires continued focus.
- Higher restructuring and quality-related costs impacted results.
Revenue & Expenses
Visualization of income flow from segment revenue to net income